logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Hosako, Ken
    Born in September 1971
    Individual (1 offspring)
    Officer
    2021-04-01 ~ now
    OF - Director → CIF 0
  • 2
    Abbott, Paul Austin
    Born in September 1972
    Individual (1 offspring)
    Officer
    2023-07-17 ~ now
    OF - Director → CIF 0
  • 3
    14-18, Takatsuji-cho, Mizuho-ku, Nagoya, 467-8525, Japan
    Corporate (1 offspring)
    Person with significant control
    2018-12-20 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 22
  • 1
    Webster, Kenneth Jeffery
    Chart Group Cfo born in March 1962
    Individual
    Officer
    2016-04-15 ~ 2017-03-01
    OF - Director → CIF 0
  • 2
    Harris, Jillian C
    Chief Financial Officer born in February 1978
    Individual (14 offsprings)
    Officer
    2017-03-01 ~ 2018-12-20
    OF - Director → CIF 0
  • 3
    Fischman, James Allen
    Group Finance Director born in September 1971
    Individual
    Officer
    2010-10-28 ~ 2014-09-30
    OF - Director → CIF 0
  • 4
    De Pledge, Paul
    Individual
    Officer
    2010-10-07 ~ 2018-12-20
    OF - Secretary → CIF 0
  • 5
    Pope, Ian
    Director born in July 1962
    Individual
    Officer
    2002-04-24 ~ 2003-08-27
    OF - Director → CIF 0
  • 6
    Estes, Nicholas Scott
    Vp Finance born in January 1979
    Individual
    Officer
    2017-05-16 ~ 2018-12-20
    OF - Director → CIF 0
    Estes, Nicholas Scott
    Chief Financial Officer, Caire Inc born in January 1979
    Individual
    2019-04-01 ~ 2022-11-25
    OF - Director → CIF 0
  • 7
    Shaw, Steven Thomas
    Director born in April 1961
    Individual
    Officer
    2002-04-24 ~ 2016-01-08
    OF - Director → CIF 0
  • 8
    Bies Iii, Frank Roger
    Vp Biomedical Group Chart born in July 1959
    Individual
    Officer
    2014-09-30 ~ 2018-12-20
    OF - Director → CIF 0
  • 9
    Romaine, John
    Individual
    Officer
    2002-04-24 ~ 2003-01-12
    OF - Secretary → CIF 0
  • 10
    Banagan, Eric Arthur Winston
    Operations Manager born in May 1958
    Individual (1 offspring)
    Officer
    2010-10-28 ~ 2014-09-30
    OF - Director → CIF 0
  • 11
    Blackham, Ian Lewis
    Manager born in March 1960
    Individual
    Officer
    2003-08-27 ~ 2010-10-28
    OF - Director → CIF 0
  • 12
    Des Lauries, Dino
    Individual
    Officer
    2003-08-27 ~ 2004-05-18
    OF - Secretary → CIF 0
  • 13
    Holmes, Arthur
    Director born in January 1941
    Individual
    Officer
    2002-04-24 ~ 2003-09-23
    OF - Director → CIF 0
  • 14
    Takayanagi, Yoshiyuki
    Company Manager born in August 1965
    Individual
    Officer
    2018-12-20 ~ 2021-04-01
    OF - Director → CIF 0
  • 15
    Grenell, David J
    Legal Counsel
    Individual
    Officer
    2003-01-12 ~ 2003-08-27
    OF - Secretary → CIF 0
  • 16
    Biehl, Michael
    Director born in March 1955
    Individual
    Officer
    2003-01-12 ~ 2016-04-15
    OF - Director → CIF 0
  • 17
    Rioux, Christopher Francis
    Finance Director born in May 1985
    Individual
    Officer
    2014-09-30 ~ 2017-05-16
    OF - Director → CIF 0
  • 18
    Lawson, Earl David
    Caire Inc President born in April 1968
    Individual
    Officer
    2016-12-22 ~ 2023-07-17
    OF - Director → CIF 0
  • 19
    Thomas, Samuel F
    Director born in August 1951
    Individual
    Officer
    2004-05-18 ~ 2017-04-13
    OF - Director → CIF 0
  • 20
    Sadowski, James
    Director born in January 1941
    Individual
    Officer
    2002-04-24 ~ 2002-07-01
    OF - Director → CIF 0
  • 21
    2, Rue Des Dahlias, Luxembourg, Luxembourg
    Corporate
    Person with significant control
    2016-04-06 ~ 2018-12-20
    PE - Ownership of shares – 75% or more → CIF 0
  • 22
    28TH FLOOR SECRETARIES LIMITED - now
    Floor 25 Tower 42, 25 Old Broad Street, London
    Dissolved Corporate (1 offspring)
    Officer
    2001-08-07 ~ 2002-04-24
    PE - Director → CIF 0
    2001-08-07 ~ 2002-04-24
    PE - Secretary → CIF 0
    2004-05-18 ~ 2010-10-07
    PE - Secretary → CIF 0
parent relation
Company in focus

CAIRE MEDICAL LTD.

Previous names
CHART BIOMEDICAL LIMITED - 2019-02-27
H H & P NINE LIMITED - 2002-04-30
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Cost of Sales
-0 USD2023-04-01 ~ 2024-03-31
-2,000 USD2022-04-01 ~ 2023-03-31
Administrative Expenses
-1,000 USD2023-04-01 ~ 2024-03-31
-2,000 USD2022-04-01 ~ 2023-03-31
Operating Profit/Loss
0 USD2023-04-01 ~ 2024-03-31
0 USD2022-04-01 ~ 2023-03-31
Other Interest Receivable/Similar Income (Finance Income)
0 USD2023-04-01 ~ 2024-03-31
Profit/Loss on Ordinary Activities Before Tax
0 USD2023-04-01 ~ 2024-03-31
0 USD2022-04-01 ~ 2023-03-31
Gross Profit/Loss
0 USD2022-04-01 ~ 2023-03-31
Interest Payable/Similar Charges (Finance Costs)
-0 USD2022-04-01 ~ 2023-03-31
Fixed Assets
0 USD2024-03-31
1,000 USD2023-03-31
Debtors
2,000 USD2024-03-31
5,000 USD2023-03-31
Cash and Cash Equivalents
1,000 USD2024-03-31
1,000 USD2023-03-31
Current Assets
3,000 USD2024-03-31
6,000 USD2023-03-31
Creditors
Current
-0 USD2024-03-31
-0 USD2023-03-31
Net Current Assets/Liabilities
3,000 USD2024-03-31
5,000 USD2023-03-31
Total Assets Less Current Liabilities
3,000 USD2024-03-31
6,000 USD2023-03-31
Creditors
Non-current
0 USD2024-03-31
-0 USD2023-03-31
0 USD2023-03-31
Net Assets/Liabilities
3,000 USD2024-03-31
5,000 USD2023-03-31
Equity
Called up share capital
0 USD2024-03-31
0 USD2023-03-31
Retained earnings (accumulated losses)
3,000 USD2024-03-31
5,000 USD2023-03-31
6,000 USD2022-03-31
Equity
3,000 USD2024-03-31
5,000 USD2023-03-31
6,000 USD2022-03-31
Profit/Loss
Retained earnings (accumulated losses)
0 USD2023-04-01 ~ 2024-03-31
0 USD2022-04-01 ~ 2023-03-31
Audit Fees/Expenses
0 USD2023-04-01 ~ 2024-03-31
0 USD2022-04-01 ~ 2023-03-31
Average Number of Employees
132023-04-01 ~ 2024-03-31
142022-04-01 ~ 2023-03-31
Wages/Salaries
1,000 USD2023-04-01 ~ 2024-03-31
1,000 USD2022-04-01 ~ 2023-03-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
0 USD2023-04-01 ~ 2024-03-31
0 USD2022-04-01 ~ 2023-03-31
Staff Costs/Employee Benefits Expense
1,000 USD2023-04-01 ~ 2024-03-31
1,000 USD2022-04-01 ~ 2023-03-31
Current Tax for the Period
-0 USD2022-04-01 ~ 2023-03-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
0 USD2023-04-01 ~ 2024-03-31
0 USD2022-04-01 ~ 2023-03-31
Tax Expense/Credit at Applicable Tax Rate
0 USD2023-04-01 ~ 2024-03-31
0 USD2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Land and buildings, Under hire purchased contracts or finance leases
0 USD2024-03-31
1,000 USD2023-03-31
Plant and equipment
0 USD2024-03-31
0 USD2023-03-31
Furniture and fittings
0 USD2024-03-31
0 USD2023-03-31
Property, Plant & Equipment - Gross Cost
0 USD2024-03-31
1,000 USD2023-03-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
0 USD2023-04-01 ~ 2024-03-31
Furniture and fittings
-0 USD2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Other Disposals
-1,000 USD2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Under hire purchased contracts or finance leases
0 USD2024-03-31
0 USD2023-03-31
Plant and equipment
0 USD2024-03-31
0 USD2023-03-31
Furniture and fittings
0 USD2024-03-31
0 USD2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
0 USD2024-03-31
1,000 USD2023-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
0 USD2023-04-01 ~ 2024-03-31
Furniture and fittings
-0 USD2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-1,000 USD2023-04-01 ~ 2024-03-31
Trade Debtors/Trade Receivables
0 USD2024-03-31
0 USD2023-03-31
Prepayments
Current
0 USD2024-03-31
0 USD2023-03-31
Creditors
0 USD2024-03-31
0 USD2023-03-31
Trade Creditors/Trade Payables
Current
0 USD2024-03-31
0 USD2023-03-31
Amounts owed to group undertakings
Current
0 USD2024-03-31
0 USD2023-03-31
Accrued Liabilities
Current
0 USD2024-03-31
0 USD2023-03-31
Number of Shares Issued (Fully Paid)
30,075,569 shares2024-03-31
30,075,569 shares2023-03-31
  • CAIRE MEDICAL LTD.
    Info
    CHART BIOMEDICAL LIMITED - 2019-02-27
    H H & P NINE LIMITED - 2019-02-27
    Registered number 04266119
    85 Great Portland Street, Great Portland Street, London W1W 7LT
    PRIVATE LIMITED COMPANY incorporated on 2001-08-07 (24 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.